# Study to Assess the Kinetic of the Analgesic Effect and Tolerability of Eschscholtzia Californica Versus Ibuprofen and Placebo in the Treatment of Pain After Surgery of the Third Molar

> **NCT02187588** · PHASE2 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 200 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Eschscholtzia Californica - low dose
- **DRUG:** Eschscholtzia Californica - high dose
- **DRUG:** Ibuprofen
- **DRUG:** Eschscholtzia Californica - low dose Placebo
- **DRUG:** Eschscholtzia Californica - high dose Placebo
- **DRUG:** Ibuprofen Placebo

## Key facts

- **NCT ID:** NCT02187588
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-02
- **Primary completion:** 1999-05
- **Final completion:** —
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2014-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02187588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02187588, "Study to Assess the Kinetic of the Analgesic Effect and Tolerability of Eschscholtzia Californica Versus Ibuprofen and Placebo in the Treatment of Pain After Surgery of the Third Molar". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02187588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*